Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Infect Drug Resist ; 16: 4455-4461, 2023.
Article in English | MEDLINE | ID: mdl-37449246

ABSTRACT

We report a case of Clostridium ramosum bacteremia in a 73-year-old patient with SARS-CoV-2 infection and right lower abdominal tenderness in China. The microbiological features and genomic epidemiological characteristics of C. ramosum worldwide were investigated to identify the possible sources of infection. Whole-genome sequencing of C. ramosum WD-I2 was performed using an Illumina NovaSeq 6000 platform. Phylogenetic analysis of C. ramosum WD-I2 and other publicly available C. ramosum isolates was performed and visualized using the interactive Tree of Life (iTOL) web server. The resistome of C. ramosum WD-I2 consists of two antimicrobial resistance genes (tetM and ermB), which explains the antimicrobial resistance trait to tetracycline and macrolides. Phylogenetic analysis showed that the strain closest to our isolated strain WD-I2 was SUG1069, recovered from a pig feces sample from Canada, which differed by 589 SNPs. To our knowledge, this is the first report of C. ramosum bacteremia in China. Our findings highlight the potential risk of invasive C. ramosum infections during the COVID-19 pandemic.

2.
Recent Pat Nanotechnol ; 17(2): 144-149, 2023.
Article in English | MEDLINE | ID: mdl-35570552

ABSTRACT

BACKGROUND: In this patent article, a novel bismuth tungstate/preoxidized acrylonitrile/ acrylic acid (AN/AA) copolymer composite nanofiber membrane was prepared, which was used as the visible light catalyst. METHODS: AN/AA copolymer was synthesized, which was electrospun with bismuth nitrate and sodium tungstate to prepare the composite nanofiber. Then the composite nanofiber was preoxidized to prepare the bismuth tungstate/preoxidized AN/AA composite nanofiber membrane containing adsorption moiety and photocatalytic active moiety. RESULTS: The photocatalytic activity of bismuth tungstate/preoxidized AN/AA composite nanofiber membrane with different preoxidized temperature, heating rate, and holding time by catalytic degradation of methylene blue was investigated. The optimal preoxidized conditions were as follows: the preoxidized temperature was heated to 200 °C with the heating rate of 1°C/min and the holding time at this temperature was 12 h. The chemical structure and morphology of the composite nanofiber membrane were characterized by FTIR, XRD, and SEM. CONCLUSION: The bismuth tungstate/preoxidized AN/AA composite nanofiber membrane obtained good photocatalytic properties and reusability under visible light. The degradation rate of methylene blue by this visible light catalyst could reach 90.24% for 4.5 h, and the degradation rate remained 81.53% for 4.5 h after 5 reuses.

3.
DNA Repair (Amst) ; 111: 103278, 2022 03.
Article in English | MEDLINE | ID: mdl-35124372

ABSTRACT

Gastric cancer (GC) is the third leading cause of cancer-associated mortality worldwide. The platinum derivative oxaliplatin is widely applied in standard GC chemotherapy but recurrence and metastasis are common in advanced GC cases due to intrinsic or induced chemoresistance. Poly(ADP-Ribose) polymerase 1 (PARP1) is an enzyme crucial for repairing DNA damage induced by platinum compounds, which undermines the effectiveness of platinum-based chemotherapy. Data from the current study showed that topoisomerase IIß binding protein 1 (TOPBP1), an interacting partner of topoisomerase IIß, is highly expressed in oxaliplatin-resistant GC (OR-GC) cells and promotes PARP1 transcription through direct binding to its proximal promoter region. Furthermore, AKT-mediated phosphorylation of TOPBP1 at Ser1159 was indispensable for inducing PARP1 expression in OR-GC cells. Disruption of the TOPBP1/PARP1 regulatory pathway decreased cell viability and augmented apoptosis of OR-GC cells. The positive correlation between TOPBP1 and PARP1 was confirmed using both the TCGA database and immunohistochemical analysis of GC tissues. In GC patients receiving oxaliplatin treatment, high expression of TOPBP1 or PARP1 was associated with poor prognosis. Our finding that the TOPBP1/PARP1 pathway facilitates acquisition of oxaliplatin resistance uncovers a novel mechanism underlying platinum-based chemotherapy resistance in gastric cancer that may be utilized for developing effective therapeutic strategies.


Subject(s)
Stomach Neoplasms , Apoptosis , Carrier Proteins/metabolism , DNA-Binding Proteins/metabolism , Humans , Nuclear Proteins/metabolism , Oxaliplatin/pharmacology , Oxaliplatin/therapeutic use , Poly (ADP-Ribose) Polymerase-1/metabolism , Stomach Neoplasms/drug therapy , Stomach Neoplasms/genetics
4.
Turk J Gastroenterol ; 32(12): 996-1002, 2021 12.
Article in English | MEDLINE | ID: mdl-34876389

ABSTRACT

BACKGROUND: To determine the prevalence of Helicobacter pylori infection and the antibiotic susceptibility of H. pylori in patients after partial gastrectomy. METHODS: Patients who underwent gastroscopy from January 2009 to November 2017 and had a history of partial gastrectomy were retrospectively enrolled in the remnant stomach group. Contemporary non-gastrectomized patients with an endoscopic diagnosis of chronic gastritis were enrolled in the non-operated stomach group. The detection of H. pylori infection was performed by culture and histology. The in vitro antimicrobial susceptibility was examined by the agar dilution method on strains from gastric biopsies. RESULTS: In this study, a total of 728 gastrectomized and 5035 non-gastrectomized patients were included. There was a significantly lower prevalence of H. pylori infection in the gastric-remnant patients (8.65%) than in the non-gastrectomized patients (17.76%) (P < .001) with the diagnostic method of culture. In the gastric-remnant patients, the H. pylori strains had resistance rates to metronidazole, clarithromycin, levofloxacin, amoxicillin, and furazolidone of 100%, 20.63%, 22.22%, 0%, and 0%, respectively. In the nongastrectomized patients, H. pylori resistance to metronidazole, clarithromycin, levofloxacin, amoxicillin, and furazolidone was 90.49%, 24.61%, 21.70%, 0.22%, and 0.11%, respectively. Gastric-remnant patients had a significantly higher metronidazole resistance rate than non-gastrectomized patients (P = .005). Moreover, no significant changes in the resistance to 5 antibiotics were observed among the gastric-remnant patients from different age, gender, and surgical indication groups. CONCLUSION: Patients after partial gastrectomy showed a lower prevalence of H. pylori infection. Gastric-remnant patients were more likely to harbor metronidazole-resistant H. pylori strains.


Subject(s)
Drug Resistance, Microbial , Gastrectomy/adverse effects , Helicobacter Infections/drug therapy , Helicobacter pylori/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Female , Gastroscopy , Helicobacter Infections/diagnosis , Helicobacter Infections/epidemiology , Helicobacter pylori/isolation & purification , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Postoperative Complications , Prevalence , Retrospective Studies , Young Adult
5.
Vet Microbiol ; 252: 108930, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33290999

ABSTRACT

Our previous research obtained purified recombinant porcine interferon-α (rPoIFN-α) containing thioredoxin (Trx) fusion tag in E. coli Rosetta (DE3). Here, we evaluate the efficacy of this rPoIFN-α to prevent piglets from the infection of the transmissible gastroenteritis virus (TGEV) attack. In this experiment, twenty-five TGEV-seronegative piglets were randomly divided into five groups. Group 1 was positive control and only challenged with TGEV; Pigs in groups 2-4 were pretreated with 2 × 10(7)IU/pig, 2 × 10(6)IU/pig, and 2 × 10(5)IU/pig rPoIFN-α before TGEV challenge. The fifth group is a negative control group. The animals of this group are pretreated only with Trx protein-containing PBS solution without TGEV challenge. After 48 h of rPoIFN-α pretreatment, the pigs in groups 1-4 were challenged by TGEV, and the pigs in group 5 were administered with PBS. The surveillance results show that Pigs pre-treated with 2 × 10 (7) IU/pig rPoIFN-α are fully aligned with the violent TGEV attack. Pigs pretreated with 2 × 10 (6) IU/pig rPoIFN-α are partially aligned with the violent TGEV attack. Though piglets pretreated with 2 × 10(6) IU/pig or 2 × 10(5)IU/pig rPoIFN-α cannot be adapted to the challenge of TGEV. However, the use of this dose of rPoIFN-α could put off the clinical signs of pigs than the positive control group of the above. These results indicate that rPoIFN-α can protect pigs from the infection of potential TGEV or delay the appearance of clinical symptoms, and its effect is dose-dependent.


Subject(s)
Escherichia coli/genetics , Gastroenteritis, Transmissible, of Swine/prevention & control , Interferon-alpha/metabolism , Transmissible gastroenteritis virus/immunology , Animals , Escherichia coli/isolation & purification , Gastroenteritis, Transmissible, of Swine/virology , Interferon-alpha/genetics , Recombinant Proteins , Swine
6.
Chemosphere ; 265: 128706, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33139052

ABSTRACT

Ambient fine particulate matter (particle diameter < 2.5 µm, or PM2.5) is a major public health concern in China. Exposure to PM2.5 has been associated with a wide range of adverse health outcomes. The current study aimed to estimate the association between exposure to PM2.5 and the risk of peptic ulcer diseases (PUDs). We conducted a hospital-based cross-sectional study of seven major cities in Zhejiang Province, China (combined population > 57 million people), which included a total of 647,092 subjects who underwent gastroscopy examination (86,852 subjects were diagnosed with PUDs) recorded in 13 large hospitals from 2014 to 2018. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the relationship between PM2.5 and PUDs, including duodenal ulcers (DUs) and gastric ulcers (GUs). The overall estimated OR (95% CI) associated with every 10-µg/m3 increase in the 1-month average PM2.5 before the detection of PUDs was 1.050 (95% CI: 1.038, 1.063). The association between PM2.5 concentration and the prevalence of PUDs tended to be attenuated but remained significant when considering different exposure periods (OR = 1.030, 95% CI = 1.018-1.043 for the 3-month moving average; OR = 1.020, 95% CI = 1.005-1.037 for the 6-month moving average). Stronger associations were observed for DUs than GUs. The observed positive association of PM2.5 exposure with PUDs remained significant in the two-pollutant models after adjusting for other air pollutants. Our findings could provide scientific evidence for a more general adverse role of air pollution on PUDs.


Subject(s)
Air Pollutants , Air Pollution , Peptic Ulcer , Air Pollutants/adverse effects , Air Pollutants/analysis , Air Pollution/adverse effects , Air Pollution/analysis , China/epidemiology , Cross-Sectional Studies , Environmental Exposure/adverse effects , Environmental Exposure/analysis , Humans , Particulate Matter/analysis
7.
J Zhejiang Univ Sci B ; 20(10): 861-864, 2019.
Article in English | MEDLINE | ID: mdl-31489805

ABSTRACT

Rectal neuroendocrine neoplasms (NENs) are low-grade malignancies, which are slow-growing and usually become symptomatic late in the course of the disease (Basuroy et al., 2016). In recent years, rectal NENs are increasingly frequently detected, with the widespread availability and accessibility of endoscopy and cross-sectional imaging modalities (Kos-Kudla et al., 2017). Multiple studies have shown that endoscopic ultrasound (EUS) is an advanced endoscopic technique and is currently used in the diagnosis and preoperative assessment of NENs (Kim, 2012; Liu et al., 2013; Zhang et al., 2017). However, EUS imaging of rectal NEN and differential diagnosis with other submucosal tumors (SMTs) has not been adequately reported. In this study, we reviewed and summarized the EUS imaging and pathological features of rectal NENs of 38 cases to improve preoperative diagnosis rate and reduce unreasonable treatment.


Subject(s)
Endosonography/methods , Neuroendocrine Tumors/diagnostic imaging , Rectal Neoplasms/diagnostic imaging , Adult , Aged , Female , Humans , Male , Middle Aged , Neuroendocrine Tumors/therapy , Rectal Neoplasms/therapy
8.
Int J Oncol ; 53(2): 567-578, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29901191

ABSTRACT

Colorectal cancer (CRC) is a type of cancer with a mortality rate among the highest worldwide owing to its high rate of metastasis. Therefore, inflammation-associated metastasis in the development of CRC is currently a topic of considerable interest. In the present study, the pro-inflammatory cytokine interleukin-4 (IL-4) was identified to promote the epithelial-mesenchymal transition (EMT) of CRC cells. However, the enhancing effect of IL-4 was more evident in HCT116 cells compared with in RKO cells. Accordingly, an increased expression level of STAT6 was observed in HCT116 cells compared with RKO cells. Further investigations identified that E2F1 was required for maintaining the level of signal transducer and activator of transcription 6 (STAT6) in HCT116 cells. Mechanistically, E2F1 induced specificity protein 3 (SP3) directly by binding to the promoter of the STAT6 gene and activating its transcription in CRC cells. As a result, phosphorylation-activated STAT6 increased the expression of several EMT drivers, including zinc finger E-box-binding homeobox (Zeb)1 and Zeb2, which serve a critical function in IL-4-induced EMT. Rescue experiments further confirmed that IL-4-induced EMT relied on an intact E2F1/SP3/STAT6 axis in CRC cells. Finally, analysis of clinical CRC specimens revealed a positive correlation between E2F1, SP3 and STAT6. The ectopically expressed E2F1/SP3/STAT6 axis indicated a poor prognosis in patients with CRC. In conclusion, the E2F1/SP3/STAT6 pathway was identified to be essential for IL-4 signaling-induced EMT and aggressiveness of CRC cells.


Subject(s)
Colorectal Neoplasms/metabolism , E2F1 Transcription Factor/metabolism , Interleukin-4/metabolism , STAT6 Transcription Factor/genetics , Sp3 Transcription Factor/metabolism , Animals , Cell Proliferation , Colorectal Neoplasms/genetics , Epithelial-Mesenchymal Transition , Female , Gene Expression Regulation, Neoplastic , HCT116 Cells , HT29 Cells , Humans , Male , Mice , Neoplasm Transplantation , Promoter Regions, Genetic , STAT6 Transcription Factor/metabolism , Signal Transduction
9.
Ann Clin Microbiol Antimicrob ; 17(1): 10, 2018 Mar 22.
Article in English | MEDLINE | ID: mdl-29562911

ABSTRACT

BACKGROUND: Clarithromycin (CLR) resistance has become a predominant factor for treatment failure of Helicobacter pylori eradication. Although the molecular mechanism of CLR resistance has been clearly understood in H. pylori, it is lack of evidence of other genes involved in drug resistance. Furthermore, the molecular mechanism of phenotype susceptible to CLR while genotype of 23S rRNA is mutant with A2143G is unclear. Here, we characterized the mutations of CLR-resistant and -susceptible H. pylori strains to explore bacterial resistance. METHODS: In the present study, the whole genomes of twelve clinical isolated H. pylori strains were sequenced, including two CLR-susceptible strains with mutation of A2143G. Single nucleotide variants (SNVs) were extracted and analyzed from multidrug efflux transporter genes. RESULTS: We did not find mutations associated with known CLR-resistant sites except for controversial T2182C outside of A2143G in the 23S rRNA gene. Although total SNVs of multidrug efflux transporter gene and the SNVs of HP0605 were significant differences (P ≤ 0.05) between phenotype resistant and susceptible strains. There is no significant difference in SNVs of RND or MFS (HP1181) family. However, the number of mutations in the RND family was significantly higher in the mutant strain (A2143G) than in the wild type. In addition, three special variations from two membrane proteins of mtrC and hefD were identified in both CLR-susceptible strains with A2143G. CONCLUSIONS: Next-generation sequencing is a practical strategy for analyzing genomic variation associated with antibiotic resistance in H. pylori. The variations of membrane proteins of the RND family may be able to participate in the regulation of clinical isolated H. pylori susceptibility profiles.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Genes, rRNA/genetics , Helicobacter pylori/genetics , High-Throughput Nucleotide Sequencing/methods , Mutation , Anti-Bacterial Agents/pharmacology , Clarithromycin/pharmacology , DNA, Bacterial/genetics , Genotype , Helicobacter Infections/microbiology , Humans , Microbial Sensitivity Tests , Phenotype , RNA, Ribosomal, 23S/genetics , Whole Genome Sequencing
10.
Cancer Lett ; 415: 58-72, 2018 02 28.
Article in English | MEDLINE | ID: mdl-29203250

ABSTRACT

As a third-generation platinum drug, oxaliplatin has been widely applied in colorectal cancer (CRC); however, acquired resistance to oxaliplatin has become a major obstacle. In the present study, we found that the nuclear transcription factor Y subunit beta (NFYB) and E2F transcription factor 1 (E2F1) expression levels were significantly higher in oxaliplatin-resistant DLD1 and RKO CRC (OR-CRC) cells than in non-resistant cells. Additionally, highly expressed NFYB transactivated the E2F1 gene, which is important to maintain oxaliplatin resistance in OR-CRC cells. And Sirt1-dependent deacetylation suppresses the proapoptotic activity of E2F1 in OR-CRC cells. Through profiling the transcriptome of OR-CRC cells following E2F1 knockdown, CHK1 was identified as a target of E2F1. Deprivation of CHK1 sensitized OR-CRC cells to oxaliplatin. In vitro and in vivo phenotype experiments confirmed that an intact NFYB-E2F1-CHK1 axis was required to suppress oxaliplatin-induced apoptosis and maintain the tumorigenicity in OR-CRC cells. Knockdown of E2F1 in OR-CRC cells also decreased the expression of Pol κ, which was essential for CHK1 activation. Consistently, a high level of NFYB, E2F1, or CHK1 predicted poor survival in CRC patients, especially with oxaliplatin treatment. Collectively, the NFYB-E2F1 pathway displays a crucial role in the chemoresistance of OR-CRC by inducing the expression and activation of CHK1, providing a possible therapeutic target for oxaliplatin resistance in CRC.


Subject(s)
CCAAT-Binding Factor/genetics , Checkpoint Kinase 1/genetics , Colorectal Neoplasms/genetics , Drug Resistance, Neoplasm/genetics , E2F1 Transcription Factor/genetics , Organoplatinum Compounds/pharmacology , Aged , Animals , Antineoplastic Agents/pharmacology , CCAAT-Binding Factor/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/genetics , Checkpoint Kinase 1/metabolism , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , E2F1 Transcription Factor/metabolism , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Male , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Oxaliplatin , RNA Interference , Signal Transduction/drug effects , Signal Transduction/genetics , Survival Analysis , Transplantation, Heterologous
11.
Tumour Biol ; 39(6): 1010428317705034, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28653891

ABSTRACT

Hypoxia plays a critical role in the progression and metastasis of hepatocellular carcinoma by activating the key transcription factor, hypoxia-inducible factor-1. This study aims to identify the novel mechanisms underlying the dysregulation of hypoxia-inducible factor-1α in hepatocellular carcinoma. We found that histone deacetylase 5, a highly expressed histone deacetylase in hepatocellular carcinoma, strengthened the migration and invasion of hepatocellular carcinoma cells under hypoxia but not normoxia condition. Furthermore, histone deacetylase 5 induced the transcription of hypoxia-inducible factor-1α by silencing homeodomain-interacting protein kinase-2 expression, which was also dependent on hypoxia. And then knockdown of hypoxia-inducible factor-1α decreased the expressions of mesenchymal markers, N-cadherin, and Vimentin, as well as matrix metalloproteinases, MMP7 and MMP9; however, the epithelial marker, E-cadherin, increased. Phenotype experiments showed that the migration and invasion of hepatocellular carcinoma cells were impaired by knockdown of histone deacetylase 5 or hypoxia-inducible factor-1α but rescued when eliminating homeodomain-interacting protein kinase-2 in hepatocellular carcinoma cells, which suggested the critical role of histone deacetylase 5-homeodomain-interacting protein kinase-2-hypoxia-inducible factor-1α pathway in hypoxia-induced metastasis. Finally, clinical analysis confirmed the positive correlation between histone deacetylase 5 and hypoxia-inducible factor-1α in hepatocellular carcinoma specimens and a relatively poor prognosis for the patients with high levels of histone deacetylase 5 and hypoxia-inducible factor-1α. Taken together, our findings demonstrated a novel mechanism underlying the crosstalk between histone deacetylase 5 and hypoxia-inducible factor-1 in hepatocellular carcinoma.


Subject(s)
Carcinoma, Hepatocellular/genetics , Carrier Proteins/genetics , Histone Deacetylases/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Liver Neoplasms/genetics , Protein Serine-Threonine Kinases/genetics , Aged , Carcinoma, Hepatocellular/pathology , Carrier Proteins/antagonists & inhibitors , Cell Hypoxia/genetics , Cell Movement/genetics , Cell Proliferation/genetics , Female , Humans , Liver Neoplasms/pathology , Male , Middle Aged , Neoplasm Invasiveness/genetics , Neoplasm Proteins/biosynthesis , Protein Serine-Threonine Kinases/antagonists & inhibitors
12.
Oncotarget ; 7(47): 78055-78068, 2016 Nov 22.
Article in English | MEDLINE | ID: mdl-27801665

ABSTRACT

As the small subunit of Ribonucleotide reductase (RR), RRM2 displays a very important role in various critical cellular processes such as cell proliferation, DNA repair, and senescence, etc. Importantly, RRM2 functions like a tumor driver in most types of cancer but little is known about the regulatory mechanism of RRM2 in cancer development. In this study, we found that the cAMP responsive element binding protein 1 (CREB1) acted as a transcription factor of RRM2 gene in human colorectal cancer (CRC). CREB1 directly bound to the promoter of RRM2 gene and induced its transcriptional activation. Knockdown of CREB1 decreased the expression of RRM2 at both mRNA and protein levels. Moreover, knockdown of RRM2 attenuated CREB1-induced aggressive phenotypes of CRC cells in vitro and in vivo. Analysis of the data from TCGA database and clinical CRC specimens with immunohistochemical staining also demonstrated a strong correlation between the co-expression of CREB1 and RRM2. Decreased disease survivals were observed in CRC patients with high expression levels of CREB1 or RRM2. Our results indicate CREB1 as a critical transcription factor of RRM2 which promotes tumor aggressiveness, and imply a significant correlation between CREB1 and RRM2 in CRC specimens. These may provide the possibility that CREB1 and RRM2 could be used as biomarkers or targets for CRC diagnosis and treatment.


Subject(s)
Colorectal Neoplasms/genetics , Cyclic AMP Response Element-Binding Protein/genetics , Ribonucleoside Diphosphate Reductase/genetics , Aged , Animals , Cell Proliferation/physiology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Cyclic AMP Response Element-Binding Protein/metabolism , Female , HCT116 Cells , HT29 Cells , Heterografts , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Ribonucleoside Diphosphate Reductase/metabolism , Transfection
13.
Pak J Pharm Sci ; 28(6 Suppl): 2317-20, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26687749

ABSTRACT

To observe influences of Bushen Xingnao Decoction (BSXND) on expression of vascular endothelial growth factor (VEGF), IL-1ßß and tumor necrosis factor-α (TNF-α) in brain tissues and serum level of vascular dementia rats and to investigate neuroprotective mechanism of BSXND for vascular dementia. Wistar rats were randomly divided into normal group (N group), sham operation group (S group), dementia model group (M group) and Bushen Xingnao decoction treatment group (MT group). After the model was successfully established, 2, 4, 6 weeks were regarded as observation point. Expressions of VEGF, IL-1ß and TNF-α in serum and brain of rat brain were measured by enzyme linked immunosorbent assay. The expressions of IL-1ß and TNF-α in MT group were lower than those in M group (P&< 0.05), the expression of VEGF in MT group was higher than that in M group (P&< 0.05); the expressions of VEGF, IL-1ß and TNF-α in MT and M groups were higher than those in N and S groups (P&<0.01). BSXND can reduce the levels of IL-1ß and TNF-α in brain tissues and serum of vascular dementia rats and increase the expression of VEGF. BSXND can play cerebral protective role by suppressing the neuroinflammation response of vascular dementia rats and enhancing vascular repair.

14.
Int J Clin Exp Med ; 8(8): 12650-5, 2015.
Article in English | MEDLINE | ID: mdl-26550178

ABSTRACT

Hepatocellular carcinoma (HCC) is one of the most frequent primary malignancies of the liver and is resistant to anticancer drugs. Hypoxia is a master cause of tumor resistance to chemotherapy. Hypoxia-inducible factor-one alpha (HIF-1α) plays a key role in the adaptive responses to hypoxic environments. HIF-1α is constitutively up-regulated in several tumor types might thus be implicated in tumor therapy resistance. We hypothesized that disruption of HIF-1α pathway could reverse the hypoxia-induced resistance to chemotherapy. In this report, we prepared DOTAP (a liposome formulation of a mono-cationic lipid N-[1-(2,3-Dioleoyloxy)]- N,N,N-trimethylammonium propane methylsulfate in sterile water) cationic liposomes containing an antisense oligonucleotide (AsODN) against HIF-1α. Gene transfer of antisense HIF-1α was effective in suppressing tumor growth, angiogenesis, and cell proliferation, and inducing cell apoptosis. Our results suggested that antisense HIF-1α therapy could be a therapeutic strategy for treating HCC.

15.
World J Gastroenterol ; 21(3): 944-52, 2015 Jan 21.
Article in English | MEDLINE | ID: mdl-25624729

ABSTRACT

AIM: To evaluate the efficacy of centralized culture and possible influencing factors. METHODS: From January 2010 to July 2012, 66452 patients with suspected Helicobacter pylori (H. pylori) infection from 26 hospitals in Zhejiang and Jiangsu Provinces in China underwent gastrointestinal endoscopy. Gastric mucosal biopsies were taken from the antrum for culture. These biopsies were transported under natural environmental temperature to the central laboratory in Hangzhou city and divided into three groups based on their transport time: 5, 24 and 48 h. The culture results were reported after 72 h and the positive culture rates were analyzed by a χ (2) test. An additional 5736 biopsies from H. pylori-positive patients (5646 rapid urease test-positive and 90 (14)C-urease breath test-positive) were also cultured for quality control in the central laboratory setting. RESULTS: The positive culture rate was 31.66% (21036/66452) for the patient samples and 71.72% (4114/5736) for the H. pylori-positive quality control specimens. In the 5 h transport group, the positive culture rate was 30.99% (3865/12471), and 32.84% (14960/45553) in the 24 h transport group. In contrast, the positive culture rate declined significantly in the 48 h transport group (26.25%; P < 0.001). During transportation, the average natural temperature increased from 4.67 to 29.14 °C, while the positive culture rate declined from 36.67% (1462/3987) to 24.12% (1799/7459). When the temperature exceeded 24 °C, the positive culture rate decreased significantly, especially in the 48 h transport group (23.17%). CONCLUSION: Transportation of specimens within 24 h and below 24 °C is reasonable and acceptable for centralized culture of multicenter H. pylori samples.


Subject(s)
Centralized Hospital Services , Gastric Mucosa/microbiology , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Microbial Sensitivity Tests , Specimen Handling/methods , Transportation , Biopsy , Centralized Hospital Services/organization & administration , China , Endoscopy, Gastrointestinal , Feasibility Studies , Helicobacter Infections/diagnosis , Humans , Predictive Value of Tests , Reproducibility of Results , Temperature , Time Factors
16.
Zhen Ci Yan Jiu ; 39(4): 278-81, 317, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25219122

ABSTRACT

OBJECTIVE: To observe the effect of acupuncture stimulation of "Dazhui" (GV 14), bilateral "Fengmen" (BL 12) and "Feishu" (BL 13) on the thickness of the bronchial tubal wall and smooth muscle and expression of transforming growth factor-beta1 (TGF-beta1) in asthma rats so as to reveal its mechanism underlying improvement of asthma. METHODS: Forty SD rats were randomly assigned to control, model, acupuncture and medication groups. The asthma model was induced by subcutaneous injection of 1% egg albumin solution and forced inhalation of atomized ovalbumin. Rats of the acupuncture group were treated by acupuncture stimulation of GV 14, bilateral BL 12 and BL 13 (once daily for 10 days), and rats of the medication group treated by intraperitoneal injection of Aminophylline Injection (100 mg/kg, once daily for 10 days). The thickness of the bronchial tubal wall and airway smooth muscle of the lung tissue were measured by image analyzer for assessing the degree of airway remodeling. The expression of TGF-beta1 in the small airway was detected by immunohistochemistry. RESULTS: Compared to the control group, the thickness of the airway wall and smooth muscle, and the expression level of TGF-beta1 were remarkably increased in the model group (P < 0.01). After acupuncture intervention and medication treatment, the thickness of the airway wall and smooth muscle, and the expression level of TGF-beta1 were remarkably down-regulated in both groups in comparison with those of the model group (P < 0.05, P < 0.01), and the expression of TGF-beta1 in the acupuncture group was obviously lower than that of the medication group (P < 0.05). CONCLUSION: Acupuncture stimulation of GV 14, bilateral BL 12 and BL 13 can down-regulate bronchial asthma-induced increase of TGF-[, expression in the lung tissue in asthma rats, which may contribute to its effect in improving airway remodeling.


Subject(s)
Acupuncture Therapy , Airway Remodeling , Asthma/therapy , Transforming Growth Factor beta1/genetics , Animals , Asthma/genetics , Asthma/metabolism , Asthma/parasitology , Bronchi/metabolism , Female , Humans , Male , Muscle, Smooth/metabolism , Rats , Rats, Sprague-Dawley , Transforming Growth Factor beta1/metabolism
17.
Zhonghua Liu Xing Bing Xue Za Zhi ; 35(6): 704-7, 2014 Jun.
Article in Chinese | MEDLINE | ID: mdl-25174476

ABSTRACT

OBJECTIVE: To study the infection status of Helicobacter pylori (H. pylori) and sensitivity to commonly used antibiotics in Taizhou district,Zhejiang province. METHODS: 39 099 cases aged between 5 and 95 years old (mean as 48.42 years) were involved during January 2010 to December, 2013 for this study. Sex ratio was 1 : 0.95. Yearly distribution of the number of cases were 5 031, 6 709, 11 902 and 15 457 in 2010, 2011, 2012 and 2013, respectively. Gastric mucosal specimens were collected and H. pylori strains were isolated and cultured in the same platform in Zhiyuan Medical Inspection Institute of Hangzhou. Resistance tests of all the H. pylori isolates were performed to 6 commonly used antibiotics:metronidazole, clarithromycin, amoxicillin, gentamicin, levofloxacin and furazolidone with the agar dilution method. The antibiotic resistance rates of H. pylori strains isolated during year 2010-2013 and the changing trends were analyzed. RESULTS: Resistance rates to levofloxacin and clarithromycin kept at higher level and the highest was in 2011 and then decreased in both 2012 and 2013 (P < 0.01). The resistance rates to both levofloxacin and clarithromycin reached the highest in 2011 (P < 0.01), and decreased thereafter, with no significant change in 2013 to 2012 (P > 0.05). CONCLUSION: Antibiotic resistance rate against metronidazole for HP isolate was highest. Resistance rate against amoxicillin and furazolidone, gentamicin was low. Clinical treatment should choose amoxicillin and furazolidone, gentamicin. The resistance rates to levofloxacin and clarithromycin had been seen at a significantly downward trend since 2011. However, the combined resistance rates to levofloxacin and clarithromycin did not seem to reduce since 2012.


Subject(s)
Drug Resistance, Multiple, Bacterial , Helicobacter pylori/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Child , Child, Preschool , Helicobacter pylori/isolation & purification , Humans , Middle Aged , Young Adult
18.
Helicobacter ; 18(4): 274-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23418857

ABSTRACT

BACKGROUND: The resistance of Helicobacter pylori (H. pylori) to antibiotics is increasing worldwide, lowering its efficacy in current eradication therapies. This study evaluated H. pylori resistance to antibiotics in the southeast coastal region of China and suggests appropriate alternatives. MATERIALS AND METHODS: Seventeen thousand seven hundred and thirty one H. pylori strains were collected from eight areas of two provinces in coastal southeast China from 2010 to 2012. The resistance of these strains to six antibiotics was tested using the agar dilution method. RESULTS: The resistance rates to clarithromycin, metronidazole, levofloxacin, amoxicillin, gentamicin and furazolidone were 21.5, 95.4, 20.6, 0.1, 0.1 and 0.1%, respectively. Double, triple and quadruple antibacterial resistant percentages were 25.5, 7.5 and 0.1%, respectively. A positive association between the resistance to levofloxacin and to clarithromycin was found, but there was a negative correlation in the resistances to levofloxacin and to metronidazole. CONCLUSIONS: The prevalence of H. pylori resistance to clarithromycin, metronidazole, levofloxacin and multiple antibiotics in coastal southeast China is high. Choice of therapy should be individualized based on a susceptibility test in this region of the country.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Helicobacter Infections/microbiology , Helicobacter pylori/drug effects , China/epidemiology , Helicobacter Infections/epidemiology , Helicobacter pylori/isolation & purification , Humans , Microbial Sensitivity Tests , Prevalence
20.
Zhongguo Zhen Jiu ; 30(8): 687-91, 2010 Aug.
Article in Chinese | MEDLINE | ID: mdl-20942290

ABSTRACT

Professor SHAO Jing-Ming devotes his life in clinical practices for more than 80 years. He is an eminent specialist acupuncture with abundant clinical experiences. He establishes the unique method of needling of tri-points and penta-needles which achieves significant effectiveness for the treatment of asthma. He has taught for more than 50 years with unique educational method. A great amount of experts appear in the circle of TCM after receiving his unique training. He devotes his life to composing books on acupuncture and moxibustion. He devotes his life and his heart to promoting the development of acupuncture and moxibustion, and makes remarkable contribution in this field.


Subject(s)
Acupuncture Therapy/history , Moxibustion/history , China , History, 20th Century , History, 21st Century , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...